301015 百洋醫藥
按盤價 
21.720 +0.670 (+3.183%)
21.720 +0.670 (+3.183%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.516 | 26.267 | 27.425 | 22.722 | 23.236 |
| 總資產報酬率 ROA (%) | 1.179 | 10.223 | 12.440 | 10.518 | 9.801 |
| 投入資產回報率 ROIC (%) | 1.575 | 13.686 | 15.948 | 12.901 | 12.402 | 邊際利潤分析 |
| 銷售毛利率 (%) | 35.818 | 35.503 | 33.295 | 27.761 | 25.127 |
| 營業利潤率 (%) | 7.888 | 12.079 | 12.641 | 8.979 | 7.963 |
| 息稅前利潤/營業總收入 (%) | 9.003 | 12.820 | 13.246 | 9.547 | 8.888 |
| 淨利潤/營業總收入 (%) | 5.957 | 9.476 | 9.335 | 6.523 | 5.885 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 143.366 | 95.706 | 97.201 | 101.354 | 97.099 |
| 價值變動淨收益/利潤總額(%) | -23.087 | 6.303 | 4.398 | -1.327 | 1.729 |
| 營業外收支淨額/利潤總額(%) | -1.366 | -1.149 | -1.519 | -0.854 | 0.696 | 償債能力分析 |
| 流動比率 (X) | 1.555 | 1.569 | 2.140 | 1.635 | 1.704 |
| 速動比率 (X) | 1.307 | 1.284 | 1.780 | 1.386 | 1.444 |
| 資產負債率 (%) | 62.837 | 63.379 | 51.391 | 54.688 | 52.767 |
| 帶息債務/全部投入資本 (%) | 53.064 | 52.596 | 37.059 | 40.604 | 41.420 |
| 股東權益/帶息債務 (%) | 84.339 | 85.200 | 162.285 | 137.491 | 139.615 |
| 股東權益/負債合計 (%) | 53.618 | 52.683 | 87.660 | 83.671 | 88.824 |
| 利息保障倍數 (X) | 7.372 | 14.594 | 16.668 | 14.817 | 10.218 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 89.666 | 90.461 | 91.822 | 93.134 | 87.171 |
| 存貨周轉天數 (天) | 66.971 | 61.697 | 49.412 | 42.270 | 42.077 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 23/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
